AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT for JONATHAN G. DRACHMAN, MDEmployment Agreement • April 17th, 2020 • Neoleukin Therapeutics, Inc. • Pharmaceutical preparations • Washington
Contract Type FiledApril 17th, 2020 Company Industry JurisdictionThis Amended and Restated Executive Employment Agreement (the “Agreement”), made between Neoleukin Therapeutics, Inc., a Delaware corporation (the “Company”), and Jonathan G. Drachman, MD (the “Executive” and, collectively with the Company, the “Parties”), is entered into as of April 15, 2020 (the “Effective Date”) and amends and restates that certain executive employment agreement entered into between the Parties as of August 5, 2019 (the “Prior Agreement”).